| Dr Albert Joseph Mastraccio Jr, OD | |
|
866 Main St, Sanford, ME 04073-3530 | |
| (207) 324-3295 | |
| (207) 324-3295 |
| Full Name | Dr Albert Joseph Mastraccio Jr |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 866 Main St, Sanford, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912077843 | NPI | - | NPPES |
| 037189 | Other | ME | ANTHEM |
| 2162488 | Other | AETNA | |
| T31672 | Other | HARVARD PILGRIM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPT652 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Albert Joseph Mastraccio Jr, OD 866 Main St, Sanford, ME 04073-3530 Ph: (207) 324-3295 | Dr Albert Joseph Mastraccio Jr, OD 866 Main St, Sanford, ME 04073-3530 Ph: (207) 324-3295 |
News Archive
An ischemic stroke occurs when a blood vessel in the brain is blocked by a blood clot which can impair brain function and cause severe disability or death. Of the 700,000 annual strokes in the US, approximately 83 percent (or 581,000) are ischemic. The Merci Retriever is a novel therapy that removes clots, restores blood flow and offers hope for ischemic stroke patients with no other options.
"In a newly released clinical study, conducted in India" and published in the Lancet on Thursday, "hundreds of seriously ill infants who received zinc - an essential micronutrient for the immune system and human growth - as well as antibiotics, responded better and more quickly to treatment than those who did not," IRIN reports.
Many cardiac implantable electronic device models currently in use were approved via a Food and Drug Administration review process in which the models were assumed safe and effective based on approval of prior versions of the device, according to a study in the January 22/29 issue of JAMA.
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced interim results of CLL-009, a study evaluating three starting doses of REVLIMID (lenalidomide), followed by step-wise dose escalation as tolerated in patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
Women who have radiotherapy for breast cancer have a small but significantly increased risk of subsequently developing a primary lung tumour, and now research has shown that this risk increases with the amount of radiation absorbed by the tissue.
› Verified 9 days ago
Dr. Daniel P. Roy, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1110 Main St, Sanford, ME 04073 Phone: 207-324-6281 Fax: 207-324-7143 | |
Kelsey Wilson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 272 Cottage St, Sanford, ME 04073 Phone: 207-324-8888 Fax: 207-490-1716 | |
Associated Eye Care, P.a. Optometrist Medicare: Medicare Enrolled Practice Location: 272 Cottage St, Sanford, ME 04073 Phone: 207-324-8888 Fax: 207-636-5023 | |
Dr. Lindsey Marie Jendrasko, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 272 Cottage St, Sanford, ME 04073 Phone: 207-324-8888 Fax: 207-490-1716 | |
Dr. Sasha Lynn Bishop, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 272 Cottage St, Sanford, ME 04073 Phone: 207-324-8888 Fax: 207-490-1716 | |
Dr. Ronald Dennis Roy, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 890 Main St, Suite 204, Sanford, ME 04073 Phone: 207-324-0400 | |
William T. Kirn, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 272 Cottage St, Sanford, ME 04073 Phone: 207-324-8888 |